aTYR PHARMA INC Contracts & Agreements

aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (Filed With SEC on May 29, 2024)

First Amendment to Lease by and between the Registrant and San Diego Creekside, LLC, dated April 8, 2024 (Filed With SEC on May 2, 2024)

Description of Common Stock of the Registrant (Filed With SEC on March 14, 2024)

Non-Employee Director Compensation Policy (Filed With SEC on March 14, 2024)

aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (Filed With SEC on May 19, 2023)

Underwriting Agreement by and between aTyr Pharma, Inc. and RBC Capital Markets, LLC (Filed With SEC on February 9, 2023)

Lease, dated May 12, 2022, by and between the Registrant and San Diego Creekside, LLC (Filed With SEC on May 16, 2022)

Forms of Grant Notice and Stock Option Agreement under aTyr Pharma, Inc. 2022 Inducement Plan (Filed With SEC on May 10, 2022)

aTyr Pharma, Inc. 2022 Inducement Plan (Filed With SEC on May 10, 2022)

aTyr Pharma, Inc. 2015 Employee Stock Purchase Plan, as amended (Filed With SEC on April 29, 2022)

aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (Filed With SEC on April 29, 2022)

Open Market Sale AgreementSM, dated April 22, 2022, by and between aTyr Pharma, Inc. and Jefferies LLC (Filed With SEC on April 22, 2022)

Common Stock Capital on DemandTM Sales Agreement, between the Registrant and JonesTrading Institutional Services LLC (Filed With SEC on March 15, 2022)

Purchase Agreement, dated September 15, 2021, by and among aTyr Pharma, Inc., Piper Sandler & Co. and RBC Capital Markets, LLC (Filed With SEC on September 16, 2021)

ATYR PHARMA, INC. 2015 STOCK OPTION AND INCENTIVE PLAN (as amended) (Filed With SEC on May 4, 2021)

First Amendment to Employment Agreement dated February 5, 2021, by and between the Company and Sanjay S. Shukla, M.D., M.S (Filed With SEC on March 24, 2021)

Amendment No. 2 to Common Stock Sales Agreement, dated November 13, 2020, between the Registrant and H.C. Wainwright & Co., LLC (Filed With SEC on November 13, 2020)

Registration Rights Agreement, dated September 11, 2020, by and between aTyr Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on September 14, 2020)

aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (Filed With SEC on May 8, 2020)

Description of Common Stock of the Registrant (Filed With SEC on March 26, 2020)

Collaboration and License Agreement by and between Registrant and Kyorin Pharmaceutical Co., Ltd. agreement, dated January 6, 2020 (Filed With SEC on February 3, 2020)

Form of Underwriting Agreement (Filed With SEC on February 3, 2020)

Common Stock Sales Agreement, dated May 21, 2019, between the Registrant and H.C. Wainwright & Co., LLC (Filed With SEC on May 22, 2019)

Employment Offer Letter by Registrant and Ms. Nancy Krueger, Esq., dated October 7, 2014 (Filed With SEC on May 14, 2019)

aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended (Filed With SEC on May 10, 2019)

Securities Purchase Agreement, dated April 10, 2019, by and among aTyr Pharma, Inc. and the investors thereunder (Filed With SEC on April 11, 2019)

Third Amendment to Lease between the Registrant and BMR-3545-3575 John Hopkins LP (as successor-in interest to BMR-John Hopkins Court, LLC), dated July 30, 2018 (Filed With SEC on November 14, 2018)

Employment Offer Letter by and between aTyr Pharma, Inc. and Jill M. Broadfoot, dated July 16, 2018 (Filed With SEC on August 1, 2018)

Employment Offer Letter by and between the Registrant and David J. King, Ph.D., dated September 13, 2016 (Filed With SEC on May 15, 2018)

Transition and Separation Agreement between Registrant and Sanuj K. Ravindran dated December 11, 2017 (Filed With SEC on March 20, 2018)

Warrant to Purchase Stock issued to Silicon Valley Bank on December 22, 2017 (Filed With SEC on March 20, 2018)

Warrant to Purchase Stock issued to Solar Capital Ltd on December 22, 2017 (Filed With SEC on March 20, 2018)

Second Amendment to Loan and Security Agreement between the Registrant and Silicon Valley Bank and Solar Capital Ltd. dated October 10, 2017 (Filed With SEC on March 20, 2018)

Third Amendment to Loan and Security Agreement between the Registrant and Silicon Valley Bank and Solar Capital Ltd. dated December 22, 2017 (Filed With SEC on March 20, 2018)

Strategic Advisor Agreement, dated November 1, 2017, by and between the Company and John D. Mendlein, Ph.D (Filed With SEC on November 14, 2017)

Employment Agreement, dated November 1, 2017, by and between the Company and Sanjay S. Shukla, M.D., M.S (Filed With SEC on November 14, 2017)

Form of Warrant to Purchase Common Stock (Filed With SEC on August 28, 2017)

Registration Rights Agreement, dated August 27, 2017, by and among the Company and the Purchasers (Filed With SEC on August 28, 2017)

Securities Purchase Agreement, dated August 27, 2017, by and among the Company and the Purchasers (Filed With SEC on August 28, 2017)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 14, 2017)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 14, 2017)

SECOND AMENDMENT TO LEASE (Filed With SEC on May 11, 2017)

aTyr Pharma, Inc. 3545 John Hopkins Court, Suite #250 San Diego CA 92121 Phone ###-###-#### Fax ###-###-#### (Filed With SEC on March 16, 2017)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on March 16, 2017)

FIRST AMENDMENT TO LEASE (Filed With SEC on March 16, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 16, 2017)

aTyr Pharma, Inc. 3545 John Hopkins Court, Suite #250 San Diego CA 92121 Phone ###-###-#### (Filed With SEC on March 16, 2017)

atyr pharma, inc. NON-QUALIFIED STOCK OPTION AGREEMENT NON-PLAN INDUCEMENT GRANT (Filed With SEC on November 14, 2016)

Amended and restated EMPLOYMENT AGREEMENT (Filed With SEC on March 30, 2016)

ATYR PHARMA, Inc. EXECUTIVE SEVERANCE AND CHANGE IN CONTROL POLICY Adopted on December 21, 2015 (Filed With SEC on March 30, 2016)

aTyr Pharma, Inc. 3565 General Atomics Court Suite 103 San Diego CA 92121 Phone ###-###-#### Fax ###-###-#### (Filed With SEC on March 30, 2016)

ATYR PHARMA, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on January 29, 2016)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on November 10, 2015)

* Confidential Information,indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission Page 1 of 27 (Filed With SEC on August 12, 2015)

aTyr Pharma, Inc. [ ] Shares of Common Stock Underwriting Agreement (Filed With SEC on May 1, 2015)

ATYR PHARMA, INC. 2015EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on April 27, 2015)

ATYR PHARMA, INC. 2014STOCK PLAN (Filed With SEC on April 27, 2015)

aTYR PHARMA, INC. 2015STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on April 27, 2015)

REGISTRATION AND VOTING RIGHTS AGREEMENT (Filed With SEC on April 27, 2015)

[AMENDED AND RESTATED] INDEMNIFICATION AGREEMENT (Filed With SEC on April 27, 2015)

LOAN AND SECURITY AGREEMENT (Filed With SEC on April 6, 2015)

LEASE by and between BMR-John Hopkins Court LLC, aDelaware limited liability company and aTyr Pharma, Inc., a Delawarecorporation LEASE (Filed With SEC on April 6, 2015)

MASTER SERVICES AGREEMENT BETWEEN ATYR PHARMA,INC. AND SYNGENE INTERNATIONAL LIMITED Page 1 of 21 Master Services Agreement This Agreement is executed on this 5th day of November... (Filed With SEC on April 6, 2015)

AMENDED AND RESTATED RESEARCH FUNDING AND OPTION AGREEMENT by and between THESCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and aTYR PHARMA, INC. a... (Filed With SEC on April 6, 2015)

AMENDED AND RESTATED RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on April 6, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on April 6, 2015)

ATYR PHARMA, INC. 2014STOCK PLAN (Filed With SEC on April 6, 2015)

SUBORDINATED CONVERTIBLE UNSECURED PROMISSORY NOTE (Filed With SEC on April 6, 2015)

WARRANT TO PURCHASE STOCK (Filed With SEC on April 6, 2015)

Category

Industry

Companies

Contracts

aTYR PHARMA INC Contracts & Agreements